Article Information
History
- May 4, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hitoshi Kawasuji1,
- Yasuhiro Tsuji2,
- Chika Ogami2,
- Yusuke Takegoshi1,
- Makito Kaneda1,
- Yushi Murai1,
- Kou Kimoto1,
- Akitoshi Ueno1,
- Yuki Miyajima1,
- Yasutaka Fukui1,
- Kentaro Nagaoka1,
- Ippei Sakamaki1,
- Yoshitomo Morinaga3 and
- Yoshihiro Yamamoto1,#
- 1Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan
- 2Center for Pharmacist Education, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi, Chiba, 274-8555, Japan
- 3Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan
- ↵#Correspondence: Yamamoto Yoshihiro, Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan., Tel: 076-434-7245, E-mail: yamamoto{at}med.u-toyama.ac.jp
Posted May 04, 2021.
Association between high serum favipiravir concentrations and drug-induced liver injury
